WSTAM
Wilbanks Smith & Thomas Asset Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-5,101
| Closed | -$333K | – | 501 |
|
|
2022
Q3 | $333K | Buy |
5,101
+633
| +14% | +$41.3K | 0.01% | 349 |
|
|
2022
Q2 | $272K | Hold |
4,468
| – | – | 0.01% | 395 |
|
|
2022
Q1 | $235K | Buy |
4,468
+1,638
| +58% | +$86.2K | 0.01% | 445 |
|
|
2021
Q4 | $214K | Sell |
2,830
-66,767
| -96% | -$5.05M | 0.01% | 480 |
|
|
2021
Q3 | $7.79M | Buy |
69,597
+67,125
| +2,715% | +$7.51M | 0.31% | 75 |
|
|
2021
Q2 | $400K | Buy |
2,472
+472
| +24% | +$76.4K | 0.02% | 344 |
|
|
2021
Q1 | $244K | Hold |
2,000
| – | – | 0.01% | 416 |
|
|
2020
Q4 | $306K | Buy |
+2,000
| New | +$306K | 0.01% | 331 |
|